stockrowQIAGEN N.V.
QGEN Healthcare Diagnostics & Research
QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.
- Revenue
- +0.28%
- EPS
- +7.94%
- Free cash flow
- +30.5%
- Total debt
- +13.8%
Quarter to June 2026, against a year earlier
Follow QGEN
Alert me
QIAGEN N.V. (QGEN) Book value per share
QIAGEN N.V.'s book value per share at the end of fiscal 2025 was 17.4×, up 8.54% from 16.0× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 16.3×. Over the past ten years it has ranged from 12.3× (fiscal 2015) to 17.6× (fiscal 2023); the current reading is higher than 91% of that period. QIAGEN N.V. ranks 17th of 49 Diagnostics & Research companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 17.4× | 8.54% |
| FY2024 | 16.0× | (8.79%) |
| FY2023 | 17.6× | 6.52% |
| FY2022 | 16.5× | 8.79% |
| FY2021 | 15.2× | 10.89% |
| FY2020 | 13.7× | 9.50% |
| FY2019 | 12.5× | (3.79%) |
| FY2018 | 13.0× | 4.35% |
| FY2017 | 12.4× | 0.34% |
| FY2016 | 12.4× | 0.95% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 16.3× | 1.11% |
| Mar 2026 | 16.1× | (7.47%) |
| Dec 2025 | 17.4× | (1.81%) |
| Sep 2025 | 17.7× | 9.50% |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| ICLR ICON PLC compare | 119× |
| CRL Charles River Laboratories International, Inc. compare | 67.6× |
| GRAL GRAIL, Inc. compare | 52.5× |
| MEDP Medpace Holdings, Inc. compare | 20.9× |
| RDNT RadNet, Inc. compare | 17.9× |
| QGEN QIAGEN N.V. | 16.3× |
| BLLN BillionToOne, Inc. compare | 0.0× |
| RVTY Revvity Inc. compare | 0.0× |
| GH Guardant Health, Inc. compare | −2.1× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on QGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement